Final results of a phase I trial of oral vorinostat (Suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma

被引：5
作者：
Richardson, Paul G. [1 ]
Mitsiades, Constantine S. [1 ]
Colson, Kathleen [1 ]
Reilly, Eileen [2 ]
McBride, Laura [2 ]
Chiao, Judy
Sun, Linda
Ricker, Justin L. [3 ]
Rizvi, Syed [3 ]
Oerth, Carol [3 ]
Atkins, Barbara [3 ]
Fearen, Ivy
Anderson, Kenneth C. [1 ]
Siegel, David S. [2 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[2] Hackensack Univ, Med Ctr, Ctr Canc, Hackensack, NJ USA
[3] Merck Res Labs, Upper Gwynedd, PA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.1179.1179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1179
引用
收藏
页码：357A / 357A
页数：1
相关论文
共 50 条
  • [31] Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL), (vol 109, pg 31, 2007)
    不详
    BLOOD, 2007, 109 (12) : 5086 - 5086
  • [32] Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma
    Crump, M.
    Coiffier, B.
    Jacobsen, E. D.
    Sun, L.
    Ricker, J. L.
    Xie, H.
    Frankel, S. R.
    Randolph, S. S.
    Cheson, B. D.
    ANNALS OF ONCOLOGY, 2008, 19 (05) : 964 - 969
  • [33] Phase I study of suberoylanilide hydroxamic acid (SAHA) and decitabine in patients with relapsed, refractory or poor prognosis leukemia
    Ravandi, Farhad
    Faderl, Stefan
    Thomas, Deborah
    Burger, Jan
    Koller, Charles
    Garcia-Manero, Guillermo
    Morris, Gail
    Torma, Ritva
    Kantarjian, Hagop
    Issa, Jean-Pierre
    BLOOD, 2007, 110 (11) : 274A - 274A
  • [34] Vorinostat (suberoylanilide hydroxamic acid, SAHA) provides prolonged safety and clinical benefit to patients with advanced cutaneous T-cell lymphoma (CTCL)
    Duvic, Madeleine
    Olsen, Elise A.
    Breneman, Debra
    Pacheco, Theresa R.
    Parker, Sardeta
    Vonderheid, Eric C.
    Ricker, Justin L.
    Rizvi, Syed
    Chen, Cong
    Boileau, Kathleen
    Cooley, Paulette
    Geskin, Larisa J.
    BLOOD, 2007, 110 (11) : 761A - 761A
  • [35] Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SARA).
    Kelly, WK
    O'Connor, O
    Richon, VM
    Curley, T
    Richardson, S
    Thapi, D
    Chiao, JH
    Rifkind, RA
    Marks, PA
    Scher, HI
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6245S - 6246S
  • [36] FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial
    Kuo, Phillip H.
    Carlson, Kacie R.
    Christensen, Inger
    Girardi, Michael
    Heald, Peter W.
    MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (06) : 306 - 314
  • [37] FDG-PET/CT for the Evaluation of Response to Therapy of Cutaneous T-cell Lymphoma to Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in a Phase II Trial
    Phillip H. Kuo
    Kacie R. Carlson
    Inger Christensen
    Michael Girardi
    Peter W. Heald
    Molecular Imaging and Biology, 2008, 10 : 306 - 314
  • [38] A phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) in patients with advanced colorectal cancer (CRC)
    Fakih, M. G.
    Pendyala, L.
    Smith, P.
    Creaven, P.
    Toth, K.
    Zwiebel, J.
    Frankel, S.
    Litwin, A.
    Huffman, L.
    Egorin, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN).
    Blumenschein, G
    Lu, C
    Kies, M
    Glisson, B
    Papadimitrakopoulou, V
    Zinner, R
    Kim, E
    Gillenwater, A
    Chiao, J
    Hong, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
  • [40] A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
    Luu, Thehang H.
    Morgan, Robert J.
    Leong, Lucille
    Lim, Dean
    McNamara, Mark
    Portnow, Jana
    Frankel, Paul
    Smith, David D.
    Doroshow, James H.
    Gandara, David R.
    Aparicio, Ana
    Somlo, George
    Wong, Carol
    CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7138 - 7142
12345